BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 14962789)

  • 21. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
    Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
    Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
    Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
    J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and application of a novel multiplex polymerase chain reaction for semi-quantitation of human Cytomegalovirus in clinical specimens.
    Madhavan HN; Sowmya P; Therese KL; Malathi J
    J Virol Methods; 2007 May; 141(2):166-72. PubMed ID: 17222918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and monitoring of cytomegalovirus infection in renal transplant patients by quantitative real-time PCR.
    Madi N; Al-Nakib W; Mustafa AS; Saeed T; Pacsa A; Nampoory MR
    Med Princ Pract; 2007; 16(4):268-73. PubMed ID: 17541291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of quantitative PCR and antigenemia in cytomegalovirus infection in renal transplant recipients.
    Bordils A; Plumed JS; Ramos D; Beneyto I; Mascarós V; Molina JM; Cordoba J; García J; Crúz JM
    Transplant Proc; 2005 Nov; 37(9):3756-9. PubMed ID: 16386529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-time PCR assay compared with antigenemia assay for detecting cytomegalovirus infection in kidney transplant recipients.
    Kim DJ; Kim SJ; Park J; Choi GS; Lee S; Kwon CD; Ki C; Joh J
    Transplant Proc; 2007 Jun; 39(5):1458-60. PubMed ID: 17580161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiplex polymerase chain reaction for the evaluation of cytomegalovirus DNA load in organ transplant recipients.
    Nazzari C; Gaeta A; Lazzarini M; Castelli TD; Mancini C
    J Med Virol; 2000 Jun; 61(2):251-8. PubMed ID: 10797382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-time polymerase chain reaction quantification of human cytomegalovirus and Epstein-Barr virus in periodontal pockets and the adjacent gingiva of periodontitis lesions.
    Kubar A; Saygun I; Ozdemir A; Yapar M; Slots J
    J Periodontal Res; 2005 Apr; 40(2):97-104. PubMed ID: 15733143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.
    Kamar N; Mengelle C; Yahyaoui S; Sandres-Sauné K; Durand D; Izopet J; Rostaing L
    J Clin Virol; 2005 May; 33(1):35-42. PubMed ID: 15797363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
    Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
    New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of pp65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients.
    Mhiri L; Kaabi B; Houimel M; Arrouji Z; Slim A
    J Virol Methods; 2007 Jul; 143(1):23-8. PubMed ID: 17336402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.
    Piiparinen H; Helanterä I; Lappalainen M; Suni J; Koskinen P; Grönhagen-Riska C; Lautenschlager I
    J Med Virol; 2005 Jul; 76(3):367-72. PubMed ID: 15902704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early diagnosis and monitoring of active HCMV infection in children with systemic lupus erythematosus.
    Zhang C; Shen K; Jiang Z; He X
    Chin Med J (Engl); 2001 Dec; 114(12):1309-12. PubMed ID: 11793860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring of human cytomegalovirus glycoprotein B genotypes using real-time quantitative PCR in immunocompromised Chinese patients.
    Fan J; Zhang X; Chen XM; Gao HN; Yang MF; Zhao H; Hu JH; Ma WH
    J Virol Methods; 2009 Sep; 160(1-2):74-7. PubMed ID: 19406161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of cytomegalovirus DNA by a fully automated real-time PCR for early diagnosis and monitoring of active viral infection in solid organ transplant recipients.
    Boaretti M; Sorrentino A; Zantedeschi C; Forni A; Boschiero L; Fontana R
    J Clin Virol; 2013 Feb; 56(2):124-8. PubMed ID: 23182772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.
    Gerna G; Baldanti F; Torsellini M; Minoli L; Viganò M; Oggionnis T; Rampino T; Castiglioni B; Goglio A; Colledan M; Mammana C; Nozza F; Daniele L;
    Antivir Ther; 2007; 12(1):63-72. PubMed ID: 17503749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
    Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of an automated extraction system in combination with Affigene CMV Trender for CMV DNA quantitative determination: comparison with nested PCR and pp65 antigen test.
    Abbate I; Finnstrom N; Zaniratti S; Solmone MC; Selvaggini S; Bennici E; Neri S; Brega C; Paterno M; Capobianchi MR
    J Virol Methods; 2008 Jul; 151(1):61-5. PubMed ID: 18462815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between pp65 antigenemia assay and quantitative real-time polymerase chain reaction for detection of active cytomegalovirus infection in routine diagnostics.
    Lugert R; Reichard U; Hufert FT; Gross U
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):192-5. PubMed ID: 19748432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.